PACE: A phase III trial of CAPOX versus anti-PD-1 inhibitor as adjuvant therapy for patients with dMMR/MSI-H stage III colon cancer

被引：0
|
作者：
Hou, Zhenlin
Jiang, Wu
Tang, Jinghua
Xiao, Binyi
Li, Yuan
Li, Dandan
Zhang, Xiaoshi
Pan, Zhi-Zhong
Ding, Peirong
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Biotherapy Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3637
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Randomized phase II trial of CAPOX with continuous versus intermittent use of oxaliplatin as an adjuvant chemotherapy after curative resection of stage II/III colon cancer (CCOG-1302 study)
    Nakamura, Masanori
    Nakayama, Goro
    Ishigure, Kiyoshi
    Mashita, Naoki
    Yokoyama, Hiroyuki
    Hattori, Norifumi
    Uehara, Keisuke
    Yamada, Suguru
    Koike, Masahiko
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [42] Adjuvant therapy for stage II and III colon cancer in elderly patients: NCDB analysis.
    Master, Samip R.
    Shi, Lawrence
    Shah, Chintan
    Shi, Runhua
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Adjuvant therapy in patients with stage II and III colon cancer under 70 years of age
    Dumont, Sarah N.
    Chibaudel, Benoist
    Bengrine-Lefevre, Leila
    Andre, Thierry
    de Gramont, Aimery
    COLORECTAL CANCER, 2013, 2 (03) : 205 - 217
  • [44] Cumulative dose of oxaliplatin in adjuvant therapy for stage III colon cancer patients: Impact on survival
    Zok, Jolanta
    Radecka, Barbara
    Adamowicz, Krzysztof
    Jan, Korniluk
    Duchnowska, Renata
    Wysokinska, Ewa Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists
    Love, N.
    Ziel, K. Ault
    Bylund, C.
    Elder, M.
    Ellis, L. M.
    Grothey, A.
    Meropol, N. J.
    Paley, D.
    Ravdin, P. M.
    Saltz, L. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma
    Stahlie, Emma H. A.
    Zijlker, Lisanne P.
    Wouters, Michel W. J. M.
    Schrage, Yvonne M.
    van Houdt, Winan J.
    van Akkooi, Alexander C. J.
    MELANOMA RESEARCH, 2024, 34 (01) : 63 - 69
  • [47] FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial (vol 36, pg 1478, 2018)
    Sobrero
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1893 - 1893
  • [48] Clinical outcomes of immune checkpoint inhibitor (ICI) therapy among Veterans Affairs patients with colorectal cancer and discordant dMMR/MSI-H status.
    Isaacs, James
    Guo, Aixia
    Vashistha, Vishal
    Katsoulakis, Evangelia
    Boswell, Elizabeth
    Strickler, John H.
    Ahmed, Sara
    Kelley, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Noninferiority of S-1 to UFT/LV as adjuvant chemotherapy for stage III colon cancer: A randomized phase III trial (ACTS-CC).
    Nakamoto, Yoshihiko
    Ishiguro, Megumi
    Yoshida, Motoki
    Ikejiri, Koji
    Mochizuki, Izumi
    Mochizuki, Hidetaka
    Kotake, Kenjiro
    Kameoka, Shingo
    Takahashi, Keiichi
    Watanabe, Toshiaki
    Watanabe, Masahiko
    Boku, Narikazu
    Tomita, Naohiro
    Matsubara, Yoshihiro
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
    Varnier, Romain
    Garrivier, Thibaut
    Hafliger, Emilie
    Favre, Aymeric
    Coutzac, Clelia
    Spire, Clement
    Rochefort, Pauline
    Sarabi, Matthieu
    Desseigne, Francoise
    Guibert, Pierre
    Cattey-Javouhey, Anne
    Funk-Debleds, Pamela
    Mastier, Charles
    Buisson, Adrien
    Perol, David
    Tredan, Oliver
    Blay, Jean-Yves
    Phelip, Jean-Marc
    de la Fouchardiere, Christelle
    FRONTIERS IN ONCOLOGY, 2021, 11
12345